BeStock  
Stocks › Biotechnology › IVA

Inventiva IVA

US equityMarket cap rank #3415Biotechnology
$3.37 −$0.10 (-2.75%)
Pre-market · Oct 8, 8:20 am ET · After hours $3.37 0.00%
Open$3.46
Prev close$3.46
Day range$3.28 – $3.46
Volume2.40M
Market cap$794.93M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2021 · reported in EUR

Revenue€65,000.00-12.2% YoY
Operating profit-€13.67M-54.3% YoY
Net profit-€14.30M-61.3% YoY
Diluted EPS-€0.37-60.9% YoY
Free cash flow-€12.13M-237.6% YoY
Operating cash flow-€12.01M

Revenue, last 4 quarters

€87.0KMar '20€74.0KJun '20€74.0KMar '21€65.0KJun '21

Net profit, last 4 quarters

€-6.8MMar '20€-8.9MJun '20€-8.8MMar '21€-14.3MJun '21

Diluted EPS by quarter

-0.23Mar '20-0.23Jun '20-0.23Mar '21-0.37Jun '21

Free cash flow by quarter

€-3.6MMar '20€-3.6MJun '20€-7.8MMar '21€-12.1MJun '21

Annual revenue

€372.0KFY20€4.2MFY21€12.2MFY22€17.5MFY23€9.2MFY24€4.5MFY25

Profitability & balance sheet

Operating margin-299,304.1%
Net margin-505,557.1%
Return on equity-989.0%
Return on assets-115.2%
Return on invested capital-255.3%
Current ratio3.81
Liabilities / assets76.5%
Cash & investments€233.89M
Total debt€64.69M
Net cash (debt)€169.21M

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Balance sheet

Line item 2026 Q2
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q2
(EUR)
2024 ANNUAL
(EUR)
Total Assets €251.21M €249.51M €249.51M €178.96M €118.97M
Total Current Assets €245.97M €244.47M €244.47M €172.81M €111.51M
Cash and Cash Equivalents & Short-Term Investments €233.89M €230.87M €230.87M €146.65M €96.56M
-Cash and Cash Equivalents €166.13M €99.31M €99.31M €122.08M €96.56M
-Short Term Investments €67.77M €131.56M €131.56M €24.58M €0.00
Receivables €10.41M €9.12M €9.12M €22.79M €12.16M
-Accounts Receivable €3.73M €2.02M €2.02M €10.76M €531,000.00
-Taxes Receivable €5.76M €5.43M €5.43M €7.47M €10.00M
-Other Receivables €919,000.00 €1.68M €1.68M €4.56M €1.63M
Prepaid Assets €1.66M €3.95M €3.95M €2.93M €2.44M
Total Non-Current Assets €5.25M €5.04M €5.04M €6.14M €7.46M
Net PPE €2.36M €2.98M €2.98M €3.99M €5.01M
-Gross PPE €17.95M €19.94M €19.94M €20.80M €20.20M
-Accumulated Depreciation -€15.59M -€16.96M -€16.96M -€16.81M -€15.19M
Investments and Advances €528,000.00 €527,000.00 €527,000.00 €835,000.00 €1.14M
-Long Term Equity Investment €528,000.00 €527,000.00 €527,000.00 €835,000.00 €1.14M
Non-Current Prepaid Assets €1.85M €1.16M €1.16M €1.05M €1.05M
Goodwill and Other Intangible Assets €310,000.00 €183,000.00 €183,000.00 €85,000.00 €48,000.00
-Other Intangible Assets €310,000.00 €183,000.00 €183,000.00 €85,000.00 €48,000.00
Non-Current Deferred Assets €197,000.00 €191,000.00 €191,000.00 €192,000.00 €217,000.00
Total Liabilities €192.21M €278.03M €278.03M €187.86M €225.61M
Total Current Liabilities €64.59M €77.38M €77.38M €58.46M €120.73M
Payables €39.08M €33.26M €33.26M €46.59M €39.72M
-Accounts Payable €34.53M €26.02M €26.02M €34.70M €32.86M
-Total Tax Payable €1.40M €1.77M €1.77M €5.59M €3.92M
-Other Payable €3.15M €5.47M €5.47M €6.30M €2.94M
Current Accrued Expenses €11.21M €10.74M €10.74M €3.28M €1.74M
Short-Term Debt and Capital Lease Obligation €13.31M €32.31M €32.31M €5.53M €5.87M
-Current Debt €11.34M €30.27M €30.27M €5.53M €3.35M
-Current Capital Lease Obligation €1.97M €2.04M €2.04M – €2.52M
Current Provisions €980,000.00 €1.07M €1.07M €3.05M –
Total Non-Current Liabilities €127.62M €200.66M €200.66M €129.41M €104.88M
Long Term Debt and Capital Lease Obligation €53.35M €27.55M €27.55M €51.60M €48.46M
-Long Term Debt €52.99M €26.82M €26.82M €51.60M €46.33M
-Long Term Capital Lease Obligation €351,000.00 €735,000.00 €735,000.00 – €2.14M
Derivative Product Liabilities €13.05M €119.39M €119.39M €42.25M €24.32M
Non-Current Deferred Liabilities €126,000.00 €126,000.00 €126,000.00 €126,000.00 €107,000.00
Employee Benefits €680,000.00 €755,000.00 €755,000.00 €891,000.00 €1.76M
Other Non-Current Liabilities €60.42M €52.84M €52.84M €34.54M €30.24M
Total Equity €59.00M -€28.52M -€28.52M -€8.91M -€106.65M
Stockholders' Equity €59.00M -€28.52M -€28.52M -€8.91M -€106.65M
Capital Stock €2.36M €1.93M €1.93M €1.39M €957,000.00
-Common Stock €2.36M €1.93M €1.93M €1.39M €957,000.00
Additional Paid-In Capital €643.92M €528.23M €528.23M €376.76M €249.16M
Retained Earnings -€69.47M -€354.14M -€354.14M -€175.88M -€184.21M
Gains/Losses Not Affecting Retained Earnings -€517.82M -€204.55M -€204.55M -€211.17M -€172.55M
Inventory – €0.00 €0.00 – €0.00
Other Current Assets – €526,000.00 €526,000.00 €437,000.00 €349,000.00
Current Deferred Liabilities – €0.00 €0.00 – €0.00
Other Current Liabilities – €1,000.00 €1,000.00 €1,000.00 €73.40M

Income statement

Line item 2025 ANNUAL
(EUR)
2024 ANNUAL
(EUR)
2023 ANNUAL
(EUR)
2022 ANNUAL
(EUR)
2021 ANNUAL
(EUR)
Total Revenue as Reported €4.48M €9.20M €17.48M €12.18M €4.19M
Total Operating Revenue €4.48M €9.20M €17.48M €12.18M €4.19M
Operating Expense €137.37M €103.19M €120.14M €69.04M €55.37M
Selling and Admin Expenses €53.89M €17.10M €15.61M €15.28M €11.34M
-Selling & Marketing Expense €4.84M €1.69M €1.76M €2.37M €151,000.00
-General & Admin Expense €49.05M €15.41M €13.85M €12.91M €11.19M
Research & Development €87.04M €90.88M €110.01M €60.47M €48.45M
Depreciation & Amortization & Depletion €253,000.00 €694,000.00 €209,000.00 €220,000.00 €176,000.00
-Depreciation & Amortization €253,000.00 €694,000.00 €209,000.00 €220,000.00 €176,000.00
Other Operating Expenses -€3.82M -€5.49M -€5.69M -€6.93M -€6.50M
Operating Profit -€132.88M -€93.99M -€102.67M -€56.86M -€51.17M
Net Non-Operating Interest Income (Expense) -€30.68M -€11.07M -€4.23M -€364,000.00 -€86,000.00
Non-Operating Interest Income €2.95M €1.14M €991,000.00 €390,000.00 €57,000.00
Non-Operating Interest Expense €33.56M €12.18M €5.18M €707,000.00 €138,000.00
Total Other Finance Costs €59,000.00 €34,000.00 €46,000.00 €47,000.00 €5,000.00
Other Income (Expense) -€190.55M -€78.84M -€2.92M €2.93M €1.99M
Gain on Sale of Security -€182.07M -€74.96M -€861,000.00 €3.06M €2.93M
Earnings from Equity Interest -€350,000.00 -€313,000.00 -€2.02M €0.00 €0.00
Special Income (Charges) -€8.13M -€3.57M -€44,000.00 -€130,000.00 -€943,000.00
-Less:Restructuring and Mergern & Acquisition €8.41M €3.72M €44,000.00 €121,000.00 €952,000.00
-Gain on Sale of Property/Plant/Equipment €285,000.00 €150,000.00 €0.00 -€9,000.00 €9,000.00
Pretax Profit -€354.11M -€183.90M -€109.82M -€54.29M -€49.28M
Tax €22,000.00 €313,000.00 €607,000.00 -€20,000.00 €364,000.00
Net Profit -€354.14M -€184.21M -€110.43M -€54.27M -€49.64M
Profit from Continuing Operations -€354.14M -€184.21M -€110.43M -€54.27M -€49.64M
Net Income to Parent Company -€354.14M -€184.21M -€110.43M -€54.27M -€49.64M
Net Income to Common Stockholders -€354.14M -€184.21M -€110.43M -€54.27M -€49.64M
Basic EPS -€1.90 -€3.08 -€2.43 -€1.31 -€1.27
Diluted EPS -€1.90 -€3.08 -€2.43 -€1.31 -€1.27
-Less:Impairment of Capital Assets – – – €0.00 –
-Less:Write Off – – – €0.00 –
Asset Impairment Loss – – – – -€333,000.00
Other Taxes – – – – €2.22M

Cash flow

Line item 2025 ANNUAL
(EUR)
2024 ANNUAL
(EUR)
2023 ANNUAL
(EUR)
2022 ANNUAL
(EUR)
2021 ANNUAL
(EUR)
Operating Cash Flow -€104.88M -€85.93M -€81.61M -€44.93M -€47.63M
Net cash flow from continuing operations -€104.89M -€85.93M -€81.61M -€44.93M -€47.63M
Net Income from Continuing Operations -€354.14M -€184.21M -€110.43M -€54.27M -€49.64M
Gain/Loss from Continuing Operations €1.74M -€518,000.00 €2.31M €343,000.00 -€5.20M
Depreciation & Depletion & Amortization €3.22M €5.20M €2.60M €1.70M -€1.29M
Deferred Tax -€2.30M -€4.80M -€4.74M -€5.26M -€3.27M
Other Non-Cash Items €213.14M €87.81M €2.15M €1.08M €737,000.00
Change in Working Capital €1.77M €1.68M €17.31M €5.71M €979,000.00
-Change in Receivables €850,000.00 €2.81M -€5.84M €3.84M -€5.32M
-Change in Inventory €0.00 €417,000.00 -€44,000.00 €19,000.00 -€72,000.00
-Change in Payables and Accrued Expense €2.56M -€3.34M €20.00M €3.54M €7.60M
-Change In Other Working Capital -€1.64M €1.79M €3.19M -€1.69M -€1.23M
Net cash flow from investing -€133.19M €8.75M -€7.73M €8.87M -€1.79M
Net Cash Flow from Continuing Investing Activities -€133.19M €8.75M -€7.73M €8.87M -€1.79M
Net PPE Purchase and Sale -€247,000.00 -€333,000.00 -€409,000.00 -€520,000.00 -€445,000.00
Net Investment Purchase and Sale -€132.94M €9.08M -€7.32M €9.39M -€1.35M
Net Other Investing Changes -€1,000.00 – – €1,000.00 €1,000.00
Financing Cash Flow €241.29M €145.59M €29.08M €37.27M €25.45M
Net Cash Flow from Continuing Financing Activities €241.29M €145.59M €29.08M €37.27M €25.45M
Net Issuance Payments Of Debt -€5.98M €19.92M -€4.10M €28.44M -€28,000.00
Net Common Stock Issuance €206.44M €57.34M €30.59M €8.83M €25.48M
Cash Dividends Paid €0.00 €0.00 €0.00 – –
Proceeds from Stock Option Exercised €58.21M €58.23M €0.00 €0.00 –
Net Other Financing Charges -€17.13M €10.10M €2.59M – –
Ending Cash Balance €99.31M €96.56M €26.92M €86.74M €86.55M
Net Change in Cash €3.22M €68.41M -€60.26M €1.21M -€23.98M
Beginning Cash Balance €96.56M €26.92M €86.74M €86.55M €105.69M
Effect of Exchange Rate Changes -€468,000.00 €1.24M €445,000.00 -€1.03M €4.84M
Free Cash Flow -€105.13M -€86.26M -€82.15M -€45.49M -€48.16M

Discussion

No comments yet — be the first to weigh in on IVA.

Leave a comment

Scroll to Top